Top Markets
Coin of the day
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Rangering i aksjer #99999
Acticor Biotech SAS operates as a clinical stage biotechnology company that... Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
Aksjekurs
$0.28545656
Markedsverdi
$4.50M
Endring (1 dag)
5.97%
Endring (1 år)
0.00%
Land
FR
Handel Acticor Biotech SAS (ALACT)

Kategori

Aksjeprishistorikk for Acticor Biotech SAS (ALACT)
Høyeste sluttskurs: $0.29 den 2024-12-01

Laveste sluttskurs: $7.56 den 2021-11-01
Aksjeprishistorikk for Acticor Biotech SAS fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2024 -90.82%
2023 -58.62%
2022 31.92%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$36.74 -53.49%
DK
$451.49 -11.91%
US
$737.00 9.61%
US
$297.72 51.37%
BE
$94.95 -40.77%
AU